PMGC Holdings (ELAB) Inventory Average (2023 - 2026)

PMGC Holdings (ELAB) posted Inventory Average of $174328.0 for Q1 2026, up 55.95% sequentially from $111783.5 in Q4 2025.

PMGC Holdings (ELAB) Inventory Average (2023 - 2026) Analysis & Trends

PMGC Holdings has reported Inventory Average for 4 years, with the latest figure at $174328.0 in Q1 2026.

Quarterly Inventory Average changed N/A year-over-year to $174328.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $174328.0 (changed N/A YoY) and the FY2023 annual result came in at $362906.0, changed N/A from the prior year.
Inventory Average improved to $174328.0 in Q1 2026 per ELAB's latest filing, from $111783.5 in the prior quarter.
Over five years, Inventory Average peaked at $249.9 million in Q4 2023 and troughed at $111783.5 in Q4 2025.
A 4-year average of $42.1 million and a median of $841085.8 in 2024 frame the typical range for Inventory Average.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory Avg. (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	1.77 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	3.09 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	213.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	707.10 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	90.57 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	196.36 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	137.65 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	PMGC Holdings	31.22 Mn	12.43 Mn	385,691.00	593,033.00

Download Data